Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ADC Therapeutics SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ADCT
New York
2836
www.adctherapeutics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ADC Therapeutics SA
ADC Therapeutics (ADCT) Is Down 69.7% After Mixed LOTIS-5 ZYNLONTA Data - Has The Bull Case Changed?
- Jun 7th, 2026 6:17 pm
Top Midday Decliners
- Jun 4th, 2026 12:25 pm
ADCT Stock Plunges on Safety Concerns Despite Positive Lymphoma Data
- Jun 4th, 2026 8:43 am
An ADC specialist sinks on safety concerns for blood cancer drug
- Jun 4th, 2026 3:27 am
ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Jun 3rd, 2026 2:05 pm
Big Pharma’s 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders
- May 14th, 2026 7:20 am
ADC Therapeutics (ADCT) Q4 2025 Earnings Call Transcript
- May 4th, 2026 5:05 pm
ADC Therapeutics S.A. Q1 2026 Earnings Call Summary
- May 4th, 2026 2:44 pm
ADCT Q1 2026 Earnings Call Transcript
- May 4th, 2026 2:23 pm
ADC Therapeutics Q1 Earnings Call Highlights
- May 4th, 2026 7:39 am
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue Estimates
- May 4th, 2026 6:35 am
ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates
- May 4th, 2026 5:30 am
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?
- May 1st, 2026 7:40 am
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
- May 1st, 2026 2:05 am
ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026
- Apr 27th, 2026 5:30 am
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
- Apr 15th, 2026 7:40 am
ADC Therapeutics Announces New Employee Inducement Grant
- Apr 1st, 2026 2:05 pm
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
- Mar 30th, 2026 7:40 am
ADC Therapeutics Eyes ZYNLONTA Expansion as LOTIS-5 Data Nears at H.C. Wainwright Chat
- Mar 26th, 2026 6:33 pm
ADC Therapeutics (ADCT) Reports 2025 Revenue of $73.6M With Cash Runway Into 2028
- Mar 18th, 2026 3:31 pm
Scroll